Skip to main content
. 2021 Oct 5;7:90. doi: 10.1038/s41421-021-00301-1

Fig. 4. FadA suppresses IL-6 through H3K9Ac.

Fig. 4

a qPCR analysis of Il6 mRNA from control or histone deacetylase (HDAC) 1–3 inhibitor CI-994-pretreated peritoneal macrophages infected with H37Rv, H37RvΔFadA, or H37Rv(ΔFadA + FadA) strains for 4 h (MOI = 1) (mean ± SEM). b qPCR analysis of Il6 mRNA from control or OSS_128167, a selective inhibitor that increases the acetylation of H3K9-pretreated peritoneal macrophages infected with H37Rv, H37RvΔFadA, or H37Rv(ΔFadA + FadA) strains for 4 h (MOI = 1) (mean ± SEM). c ChIP-seq analysis of histone H3 acetylation at the lysine 9 residue (H3K9Ac) for the Il6 promoter of peritoneal macrophage infected with H37Rv or H37RvΔFadA strains for 4 h (MOI = 1) with SimpleChIP Enzymatic Chromatin IP Kit. d ChIP-qPCR (mean ± SEM) analysis of H3K9Ac for the Il6 promoter of peritoneal macrophage infected with negative control, H37Rv, H37RvΔFadA, or H37Rv(ΔFadA + FadA) strains for 4 h (MOI = 1). Data in a, b, d represent one experiment with at least three independent replicates. One-way (d) or two-way (a, b) ANOVA with Bonferroni’s multiple comparisons test were used for statistical analysis.